221 related articles for article (PubMed ID: 35058175)
1. Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines.
Close DA; Johnston PA
SLAS Discov; 2022 Jan; 27(1):39-54. PubMed ID: 35058175
[TBL] [Abstract][Full Text] [Related]
2. Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.
Kochanek SJ; Close DA; Camarco DP; Johnston PA
SLAS Discov; 2020 Apr; 25(4):329-349. PubMed ID: 31983262
[TBL] [Abstract][Full Text] [Related]
3. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
Kochanek SJ; Close DA; Johnston PA
Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
[TBL] [Abstract][Full Text] [Related]
4. High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer.
Shan F; Close DA; Camarco DP; Johnston PA
Assay Drug Dev Technol; 2018 Jan; 16(1):27-50. PubMed ID: 29215913
[TBL] [Abstract][Full Text] [Related]
5. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
6. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures.
Essid N; Chambard JC; Elgaaïed AB
Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250
[TBL] [Abstract][Full Text] [Related]
7. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
8. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
Bache M; Kappler M; Said HM; Staab A; Vordermark D
Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic sensitizer and cytotoxin for head and neck cancer.
Lee DJ; Moini M; Giuliano J; Westra WH
Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.
Shemirani B; Crowe DL
Oral Oncol; 2002 Apr; 38(3):251-7. PubMed ID: 11978547
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-releasing nanodroplets relieve intratumoral hypoxia in head and neck cancer spheroids.
Xavierselvan M; Bednarke B; Shethia RT; Yang V; Moses L; Mallidi S
bioRxiv; 2024 May; ():. PubMed ID: 38853892
[TBL] [Abstract][Full Text] [Related]
13. ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
Keulers TG; Koch A; van Gisbergen MW; Barbeau LMO; Zonneveld MI; de Jong MC; Savelkouls KGM; Wanders RG; Bussink J; Melotte V; Rouschop KMA
Autophagy; 2022 Aug; 18(8):1898-1914. PubMed ID: 34904929
[TBL] [Abstract][Full Text] [Related]
14. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
15. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.
Bhattacharya A; Tóth K; Mazurchuk R; Spernyak JA; Slocum HK; Pendyala L; Azrak R; Cao S; Durrani FA; Rustum YM
Clin Cancer Res; 2004 Dec; 10(23):8005-17. PubMed ID: 15585636
[TBL] [Abstract][Full Text] [Related]
16. Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer.
Toustrup K; Sørensen BS; Nordsmark M; Busk M; Wiuf C; Alsner J; Overgaard J
Cancer Res; 2011 Sep; 71(17):5923-31. PubMed ID: 21846821
[TBL] [Abstract][Full Text] [Related]
17. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
Chintala S; Tóth K; Cao S; Durrani FA; Vaughan MM; Jensen RL; Rustum YM
Cancer Chemother Pharmacol; 2010 Oct; 66(5):899-911. PubMed ID: 20066420
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
Sarnella A; Ferrara Y; Auletta L; Albanese S; Cerchia L; Alterio V; De Simone G; Supuran CT; Zannetti A
J Exp Clin Cancer Res; 2022 Apr; 41(1):122. PubMed ID: 35365193
[TBL] [Abstract][Full Text] [Related]
19. Roles of hypoxia, stem cells and epithelial-mesenchymal transition in the spread and treatment resistance of head and neck cancer.
Gammon L; Mackenzie IC
J Oral Pathol Med; 2016 Feb; 45(2):77-82. PubMed ID: 25952002
[TBL] [Abstract][Full Text] [Related]
20. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.
Schilling D; Bayer C; Geurts-Moespot A; Sweep FC; Pruschy M; Mengele K; Sprague LD; Molls M
BMC Cancer; 2007 Jul; 7():143. PubMed ID: 17663760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
